Clinical Trials Browser

Neurodegenerative Diseases × Clear all

NCT06745583 2026-04-09

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Phase 2 Recruiting

15 enrolled

Lymphoid

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

NCT07446842 2026-03-06

Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases

Recruiting

1,000 enrolled

CNS

Brain Neoplasms, Neurodegenerative Diseases, Stroke

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

11 enrolled

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT06755840 2025-04-03

Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study

Recruiting

15,000 enrolled

Mental Disorders, Cardiovascular Diseases, Metabolic Diseases, Neoplasms, Nervous System Diseases, Respiratory Tract Diseases, Sleep Apnea Syndromes, Neurodegenerative Diseases, Sleep Apnea, Obstructive, Sleep Apnea, Central

NCT06251830 2024-02-09

Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?

Completed

610 enrolled

CNS

Brain Neoplasms, Epilepsy, Multiple Sclerosis, Neurodegenerative Diseases, Neurodevelopmental Disorders

NCT06211803 2024-01-18

JPETClinic

Completed

10 enrolled

CNSEndocrineNET

Brain Neoplasms, Neuroendocrine Tumors, Neurodegenerative Diseases

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT03336489 2018-12-07

DICODOM

Completed

200 enrolled

Neoplasms, Neurodegenerative Diseases

NCT03426488 2018-02-08

NSHDS

Unknown

120,000 enrolled

Cardiovascular Diseases, Infections, Neoplasms, Respiration Disorders, Neurodegenerative Diseases

NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Phase EARLY_PHASE1 Completed

10 enrolled

CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

NCT03242109 2017-08-08

The Moli-sani Study

Completed

24,325 enrolled

Cardiovascular Diseases, Diabetes Mellitus, Lung Diseases, Neoplasms, Neurodegenerative Diseases

NCT01969370 2017-05-03

NCGENES

Phase NA Completed

645 enrolled

Congenital Abnormalities, Cardiovascular Diseases, Neoplasms, Neurologic Manifestations, Neurodegenerative Diseases, Hearing Loss

NCT02108769 2014-04-09

Yogic Breathing Changes Salivary Components

Phase NA Completed

20 enrolled

Alzheimer Disease, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Neurodegenerative Diseases

NCT00643890 2012-02-22

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

Phase 2 Terminated

44 enrolled

CNS

Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, Movement Disorders, Nervous System Diseases, Parkinson Disease, Neurodegenerative Diseases, Parkinsonian Disorders, Ganglion Cysts